Roth Capital comments on Ligand Pharma (Nasdaq: LGND) after Bristol-Myers Squibb (NYSE: BMY) announced Wednesday that the European Commission approved ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE